ClinicalTrials.gov
ClinicalTrials.gov Menu

Potential Effects of Omega 3 Supplementation on Cardiomyocytes Membranes for Patients With Coronary Atherosclerosis? (CORONOMEGA3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01699230
Recruitment Status : Unknown
Verified October 2012 by University Hospital, Clermont-Ferrand.
Recruitment status was:  Recruiting
First Posted : October 3, 2012
Last Update Posted : October 3, 2012
Sponsor:
Collaborator:
Université d'Auvergne
Information provided by (Responsible Party):
University Hospital, Clermont-Ferrand

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : May 2013
  Estimated Study Completion Date : May 2013